Mirae Asset Global Etfs Holdings Ltd. Cure Vac N.V. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cure Vac N.V. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 62,310 shares of CVAC stock, worth $328,996. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,310
Previous 64,157
2.88%
Holding current value
$328,996
Previous $348,000
3.74%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CVAC
# of Institutions
103Shares Held
22.4MCall Options Held
124KPut Options Held
77.1K-
Glazer Capital, LLC New York, NY4.55MShares$24 Million0.82% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.3MShares$12.1 Million0.78% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$11.9 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X01.71MShares$9.04 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.28 Million10.6% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $990M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...